President Donald Trump left Walter Reed National Military Medical Center on Monday to return to the White House, where he will continue to be treated for the coronavirus even as he looks to restart his reelection campaign. Shortly before his…
CNBC’s Meg Tirrell takes a look at the treatments and experimental medicines President Trump is receiving for what experts are saying is a ‘severe’ case of Covid-19. For access to live and exclusive video from CNBC subscribe to CNBC PRO:…
CNBC’s Eamon Javers joins ‘Closing Bell’ to report that President Trump has received a Regeneron antibody cocktail. Trump is currently working with a team of experts receiving recommendations after he tested positive for Covid-19. For access to live and exclusive…
Moncef Slaoui, White House chief advisor of Operation Warp Speed, joins “Squawk on the Street” to discuss developments in a Coronavirus vaccine. For access to live and exclusive video from CNBC subscribe to CNBC PRO: The United States could immunize…
Speaking with CNBC’s Brian Sullivan, Oxford Vaccine Group Co-Director Adrian Hill says the Covid-19 vaccine he is helping to develop with AstraZeneca is “more than likely” to work and expects to have millions of doses ready by the end of…
A potential coronavirus vaccine developed by Oxford University in the U.K. has produced a strong immune response in a large, early-stage human trial, according to newly-released data published Monday in the medical journal, The Lancet. CNBC’s Meg Tirrell reports. Subscribe…
